Researchers identify new blood markers that may detect early pancreatic cancer

NIH-funded, four-marker panel could one day help catch one of deadliest cancers at more treatable stages

2026-01-30

(Press-News.org) For Immediate Release

Friday, January 30, 2026

Contact:

NIH Office of Communications

National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective. The findings were published in Clinical Cancer Research.

Overall, only about 1 in 10 pancreatic cancer patients survive more than five years from diagnosis. However, experts expect that when the cancer is found and treated at an earlier stage, survival would improve. While finding the cancer early is key, there are no current screening methods to do so.

In the study, scientists at the University of Pennsylvania Perelman School of Medicine, Philadelphia, and Mayo Clinic, Rochester, Minnesota, used a phased approach to testing biomarkers in the blood collected from patients with pancreatic cancer and similar patients without the malignancy. They included two blood biomarkers previously explored for use in this way, carbohydrate antigen 19-9 (CA19-9), which is used to monitor treatment response in patients with pancreatic cancer, and thrombospondin 2 (THBS2), another previously used marker. Neither worked well as a screening tool. CA19-9 can be elevated in people with benign conditions such as pancreatitis and bile duct obstruction while other patients don't produce it at all due to genetic factors.

In analyzing banked blood samples, the team found two novel biomarker proteins that were elevated in the blood of early-stage pancreatic cancer patients compared with healthy volunteers, aminopeptidase N (ANPEP) and polymeric immunoglobin receptor (PIGR).

When they combined ANPEP and PIGR with CA19-9 and THBS2 the four-marker panel successfully distinguished pancreatic cancer cases from non-cases 91.9% of the time for all stages combined at a false positive rate of 5% in non-cases. Similarly, for early-stage (stage I/II) cancer, the four-marker test identified 87.5% of cases.

"By adding ANPEP and PIGR to the existing markers, we've significantly improved our ability to detect this cancer when it's most treatable,” said the study’s lead investigator, Kenneth Zaret, Ph.D., University of Pennsylvania's Perelman School of Medicine.

Importantly, the four-marker test successfully distinguished cancer patients from both healthy individuals and those with non-cancerous pancreatic conditions, such as pancreatitis.

“Our retrospective study findings warrant further testing in larger populations, particularly in people before they show symptoms,” Zaret said. “Such ‘prediagnostic’ studies would help determine if the test could be used as a screening tool for people at high risk of developing the disease based on family history, genetic screening results or personal history of pancreatic cysts or pancreatitis.”

The study was supported by NIH grants U01CA210138, P50CA102701, S10 OD023586-01, P30 DK020579, UL1 TR002345, P30CA091842, and U01CA210138.

About the National Cancer Institute (NCI): NCI leads the National Cancer Program and NIH’s efforts to dramatically reduce the prevalence of cancer and improve the lives of people with cancer. NCI supports a wide range of cancer research and training extramurally through grants and contracts. NCI’s intramural research program conducts innovative, transdisciplinary basic, translational, clinical, and epidemiological research on the causes of cancer, avenues for prevention, risk prediction, early detection, and treatment, including research at the NIH Clinical Center—the world’s largest research hospital. For more information about cancer, please visit the NCI website at https://www.cancer.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Reference: Krusen BM, Gimotty PA, Donahue G, Till JE, Yin M, Carlson EE, Bamlet WR, Carpenter EL, Majumder S, Oberg AL, Zaret KS. “Improving a plasma biomarker panel for early detection of pancreatic ductal adenocarcinoma with aminopeptidase N (ANPEP) and polymeric immunoglobin receptor (PIGR)” Published January 29, 2026, in Clinical Cancer Research.

END

ELSE PRESS RELEASES FROM THIS DATE:

Scientists uncover why some brain cells resist Alzheimer's disease

2026-01-30

New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer’s disease and related dementias, potentially leading to new targets for therapies or treatments. The study, published in the journal Cell, used a novel CRISPR-based genetic screening approach on lab-grown human brain cells to determine the cellular machinery that controls the accumulation of tau protein in the brain. These proteins can build up as toxic clumps in the brain, killing ...

The Lancet: AI-supported mammography screening results in fewer aggressive and advanced breast cancers, finds full results from first randomized controlled trial

2026-01-30

First full results of a randomised trial investigating the use of AI in a national breast cancer screening programme finds AI-supported mammography screening is more effective across many measures than standard mammography. AI-supported breast cancer screening identified more women with clinically relevant cancers during the screening without a higher rate of false positives. Additionally, women who underwent AI-supported screening were less likely to be diagnosed with more aggressive and advanced breast cancer in the two years following. Authors say these findings could justify implementing AI in mammography screening programmes, particularly in the context of health ...

New AI tool improves treatment of cancer patients after heart attack

2026-01-30

Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment particularly challenging. As a result, patients with cancer have been systematically excluded from many clinical trials and available risk scores. Until now, doctors had no standard tool to guide treatment in this vulnerable group. International study leverages population data An international team led by researchers from the University of Zurich (UZH) has now developed the first risk prediction model designed specifically for cancer patients who have had a heart attack. The study, published in The Lancet, analyzed more than one million heart attack patients in England, Sweden ...

Kandahar University highlights global disparities in neurosurgical workforce and access to care

2026-01-29

Neurological disorders contribute to nearly nine million deaths globally each year, and an estimated 22.6 million new cases require neurosurgical attention annually, of which approximately 13.8 million require surgical intervention. Despite this burden, access to safe and timely neurosurgical care remains limited for more than two-thirds of the world’s population, particularly in low- and middle-income countries (LMICs). This gap has increasingly been recognized as a major global public health concern. A new article, published on November 20, 2025, in the ...

Research spotlight: Discovering risk factors for long-term relapse in alcohol use disorder

2026-01-29

John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in Frontiers in Public Health, “Long-term relapse: markers, mechanisms, and implications for disease management in alcohol use disorder.” Q: What challenges or unmet needs make this study important? Alcohol use disorder (AUD) is one of leading causes of preventable death in the United States and worldwide, and leads to substantial disease and medical complication. While treatments are available that can help ...

As fossil fuel use declines, experts urge planning and coordination to prevent chaotic collapse

2026-01-29

As the world shifts toward renewable energy sources, some experts warn that a lack of planning for the retirement of fossil fuels could lead to a disorderly and dangerous collapse of existing systems that could prolong the transition to green energy. In a study published in the journal Science, University of Notre Dame researchers Emily Grubert and Joshua Lappen argue that fossil fuel systems might be far more fragile than current energy models assume. “Systems designed to be large and growing behave differently when they shrink,” said Grubert, associate professor of sustainable energy policy at ...

Scientists identify the antibody's hinge as a structural "control hub"

2026-01-29

The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo. Deleting a single amino acid in this region transforms a full-length antibody into a stable half-IgG1 molecule with altered immune activity. The findings provide a blueprint for engineering next-generation antibody therapies with precisely tailored immune effects for treating diseases such as cancer and autoimmune diseases. Antibodies are Y-shaped proteins that help the immune system recognize and eliminate foreign threats such as bacteria and viruses. ...

Late-breaking study establishes new risk model for surgery after TAVR

2026-01-29

NEW ORLEANS — January 29, 2026 — At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators will present a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR), a clinical scenario increasingly encountered as TAVR use expands. The analysis draws on data from the STS Adult Cardiac Surgery Database to characterize risk over time and to validate a dedicated STS risk model designed to support decision-making for patients requiring surgery after TAVR. The study, to be ...

To reduce CO2 emissions, policy on carbon pricing, taxation and investment in renewable energy is key

2026-01-29

A new peer-reviewed study evaluating climate policies in 40 countries over a 32-year period finds that carbon pricing and taxation—combined with investments in renewable energy and research—are among the most effective tools governments can use to reduce CO₂ emissions. Drawing on successful examples such as Sweden and Norway, which have implemented a broad mix of climate policies at varying levels of stringency, the authors conclude that countries benefit most from a comprehensive and diverse policy toolkit rather than reliance on a single measure. The research team—comprising experts from the University of Barcelona, ...

Kissing the sun: Unraveling mysteries of the solar wind

2026-01-29

Using data collected by NASA's Parker Solar Probe during its closest approach to the sun, a University of Arizona-led research team has measured the dynamics and ever-changing "shell" of hot gas from where the solar wind originates. Published in Geophysical Research Letters, the findings not only help scientists answer fundamental questions about energy and matter moving through the heliosphere – the volume of space controlled by the sun's activity – which affects not just the Earth and moon, but all ...

LAST 30 PRESS RELEASES:

Heart damage is common after an operation and often goes unnoticed, but patients who see a cardiologist may be less likely to die or suffer heart disease as a result

New tool exposes scale of fake research flooding cancer science